PALLIATIVE RADIATION DURING PEMETREXED PLUS CISPLATIN FIRST-LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PATIENT SAFETY IN THE JMDB AND PARAMOUNT TRIALS

被引：0
|
作者：
Scagliotti, G. V. [1 ]
Gridelli, C. [2 ]
de Marinis, F. [3 ]
Biesma, B. [4 ]
Reck, M. [5 ]
San Antonio, B. [6 ]
Zimmermann, A. H. [7 ]
Visseren-Grul, C. [8 ]
Chouaki, N. [9 ]
Paz-Ares, L. [10 ]
机构：
[1] Univ Turin, Turin, Italy
[2] San Giuseppe Moscati Hosp, Dept Oncol Hematol, Avellino, Italy
[3] San Camillo Forlanini Hosp, Oncol Pulm Unit 1, Rome, Italy
[4] Jeroen Bosch Hosp, Dept Pulm Dis, sHertogenbosch, Netherlands
[5] Hosp Grosshansdorf, Grosshansdorf, Germany
[6] Eli Lilly & Co, Oncol, Madrid, Spain
[7] Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA
[8] Eli Lilly & Co, Oncol Thorac, Houten, Netherlands
[9] Eli Lilly & Co, Oncol Thorac, Paris, France
[10] Seville Univ Hosp, Seville, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113P
引用
下载
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] PALLIATIVE RADIATION DURING PEMETREXED PLUS CISPLATIN FIRST-LINE TREATMENT OR PEMETREXED CONTINUATION MAINTENANCE TREATMENT IN ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A REPORT OF PATIENT SAFETY IN THE PARAMOUNT TRIAL
    De Marinis, Filippo
    Gridelli, Cesare
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Lois
    Molinier, Olivier
    Reck, Martin
    Sahoo, Tarini P.
    San Antonio, Belen
    John, William J.
    Zimmermann, Annamaria H.
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Arez, Luis G.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S842 - S843
  • [2] THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Wielage, R. C.
    Muehlenbein, C. E.
    Liepa, A. M.
    Babineaux, S. M.
    Klein, R. W.
    Schwartzberg, L. S.
    VALUE IN HEALTH, 2009, 12 (03) : A39 - A39
  • [3] EFFICACY AND SAFETY OF CISPLATIN/PEMETREXED AS FIRST-LINE TREATMENT FOR JAPANESE PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Yamaguchi, Teppei
    Nakanishi, Toru
    Hayashi, Masamichi
    Isogai, Sumito
    Hoshino, Tami
    Mieno, Yuki
    Uozu, Sakurako
    Morishita, Mariko
    Okamura, Takuya
    Takeyama, Tomoko
    Minezawa, Tomoyuki
    Morikawa, Sayako
    Niwa, Yoshikazu
    Okazawa, Mitsushi
    Imaizumi, Kazuyoshi
    RESPIROLOGY, 2013, 18 : 83 - 83
  • [4] Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase III trials
    Treat, J.
    Scagliotti, G.
    Peng, G.
    Monberg, M. J.
    Obasaju, C. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] COMPARISON OF PEMETREXED PLUS CISPLATIN WITH OTHER FIRST-LINE DOUBLETS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A COMBINED ANALYSIS OF THREE PHASE 3 TRIALS
    Treat, Joseph
    Scagliotti, Giorgio
    Peng, Guangbin
    Pohl, Gerhardt
    Obasaju, Coleman
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S415 - S416
  • [6] Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials
    Treat, Joseph
    Scagliotti, Giorgio V.
    Peng, Guangbin
    Monberg, Matthew J.
    Obasaju, Coleman K.
    Socinski, Mark A.
    LUNG CANCER, 2012, 76 (02) : 222 - 227
  • [7] FIRST LINE CHEMOTHERAPY WITH PEMETREXED PLUS CISPLATIN IN ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A COMPARISON OF TWO PHASE III TRIALS
    Scagliotti, Giorgio
    Gridelli, Cesare
    De Marinis, Filippo
    Thomas, Michael
    Dedui, Mircea
    Pujol, Jean-Louis
    Manegold, Christian
    Melemed, Symantha
    John, William
    Zimmermann, Annamaria H.
    Chouaki, Nadia
    Melemed, Allen
    Visseren-Grul, Carla
    Paz Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1160 - S1161
  • [8] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
  • [9] Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer
    Wu, Yi-Long
    Lu, Shun
    Cheng, Ying
    Zhou, Caicun
    Wang, Mengzhao
    Qin, Shukui
    Lu, You
    Zhang, Yang
    Zhu, Yunzhong
    Song, Xiangqun
    Wang, Xin
    Barraclough, Helen
    Zhang, Xiaoqing
    Chi, Haidong
    Orlando, Mauro
    LUNG CANCER, 2014, 85 (03) : 401 - 407
  • [10] Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer
    Klein, Robert
    Muehlenbein, Catherine
    Liepa, Astra M.
    Babineaux, Steve
    Wielage, Ron
    Schwartzberg, Lee
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : 1404 - 1414
12345